Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - ondansetron - film-coated tablet - serotonin (5ht3) antagonists; ondansetron

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

profind wholesale ltd - granisetron hydrochloride - film coated tablet - 1 milligram

Stati Uniti - Ingliż - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride usp is indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride usp is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Singapor - Ingliż - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - riociguat micronized - tablet, film coated - 0.50mg - riociguat micronized 0.50mg

Singapor - Ingliż - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - riociguat micronized - tablet, film coated - 1mg - riociguat micronized 1mg

Singapor - Ingliż - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - riociguat micronized - tablet, film coated - 1.50mg - riociguat micronized 1.50mg

Singapor - Ingliż - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - riociguat micronized - tablet, film coated - 2.00mg - riociguat micronized 2.00mg

Singapor - Ingliż - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - riociguat micronized - tablet, film coated - 2.50mg - riociguat micronized 2.50mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

orchidpharma inc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

northstar rx llc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.